Preventive Breast Cancer Test
PBCT works biologically downstream using a proprietary method to measure markers at the protein level to deliver a robust and personalized risk score for cancer therapy guidance.

Different chemical groups in a biomolecule absorb infrared (IR) light at very specific wavelengths. Chemists currently use this, in the form of IR spectrometry, to analyze chemistry and deduce the compositions of large molecules. The use of spectrometry is used in various fields of science and technology including chemical analysis, environmental monitoring, material characterization, forensic analysis, and astronomical studies.

PBCT is pioneering the growing use of spectrometry in cancer diagnostics. Through biopsy imaging, we analyze wavelengths that are known to be absorbed by nucleic acids and cell proteins. This imaging approach enables us to measure chemical concentrations associated with tumor malignancy, precisely determine the characteristics of cancer cells, and quantify validated pathology markers correlated to tumor proliferation.

Our technology captures a unique spectral signature from each biopsy and performs analysis on over 10,000 data points per biopsy. Using this data, PBCT proprietary artificial intelligence identifies risk profiling patterns and computes an accurate risk score – the PBCT Prognostic Score. The score provides clinicians with a single-digit number predicting the proliferation risk of sample cancer cells to guide diagnosis and adjuvant (post-surgery) chemotherapy decision-making.